Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

OncImmune

OncImmune logoOncImmune Ltd is a privately funded company based in Nottingham. The company developed the first commercially available autoantibody blood test for the early diagnosis of cancer (the EarlyCDT-Lung test).

Andrea Murray

Andrea Murray is Chief Operational Scientist at OncImmune Ltd. She joined the company when it was established in 2004 as Senior Director of Assay Development. Andrea has been involved with the EarlyCDT-Lung test through all of its stages of development and validation and has provided critical technical leadership since.

In this section

The Bio-medical Research Council (BRC), a part of the Oxford Hospital Radcliffe Trust (OHRT), funds research and many of our staff are involved in BRC research.

Our research is funded from a variety of funders. Their support allows our research to focus on the basic and clinical research domains to accelerate knowledge translation from the bedside to the bench, and back again.